Phase III trial of liposomal doxorubicin and cyclophosphamide compared with epirubicin and cyclophosphamide as first-line therapy for metastatic breast cancer-Reference-Cited by-同舟云学术

Phase III trial of liposomal doxorubicin and cyclophosphamide compared with epirubicin and cyclophosphamide as first-line therapy for metastatic breast cancer

Published:2004-10 Issue:10 Volume:15 Page:1527-1534
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Chan S.,Davidson N.,Juozaityte E.,Erdkamp F.,Pluzanska A.,Azarnia N.,Lee L.W.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/15/10/1527/406976/mdh393.pdf

Reference27 articles.

1. Treatment of metastatic disease;Honig,1996

2. Doxorubicin cardiomyopathy, a critical review;Saltiel;West J Med,1983

3. Anthracycline induced cardiotoxicity;Shan;Ann Intern Med,1996

4. Strategies for reduction of anthracycline cardiac toxicity;Speyer;Semin Oncol,1998

5. Cardiac effects of adjuvant doxorubicin and radiation therapy in breast cancer patients;Shapiro;J Clin Oncol,1998

Cited by 134 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cryo-EM reconstruction of oleate hydratase bound to a phospholipid membrane bilayer;Journal of Structural Biology;2024-09

2. Innovative Nanoscale Drug Delivery Strategies for Breast Carcinoma: A Comprehensive Exploration;Current Drug Metabolism;2024-08-06

3. Cardiovascular Toxicity of Antineoplastic Treatments in Hematological Diseases: Focus on Molecular Mechanisms to Improve Therapeutic Management;Journal of Clinical Medicine;2024-03-09

4. Administration of Inhibitory Molecules through Nanoparticles in Breast Cancer Therapy;Current Medicinal Chemistry;2024-02

5. Prospective, Multicenter Phase II Trial of Non-Pegylated Liposomal Doxorubicin Combined with Ifosfamide in First-Line Treatment of Advanced/Metastatic Soft Tissue Sarcomas;Cancers;2023-10-18